Home clinical

Keywords :   

Tag: clinical


2015-09-28 14:00:56| Merck.com - Product News

Dateline City: WALTHAM, Mass. and KENILWORTH, N.J. Clinical trial to assess safety and efficacy of immuno-oncology combination in patients with advanced NSCLC or melanoma WALTHAM, Mass. and KENILWORTH, N.J. Syndax Pharmaceuticals, Inc. and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the dosing of the first patients in the Phase 1b/2 clinical trial of Syndaxs entinostat in combination with Mercks anti-PD-1 therapy KEYTRUDA (pembrolizumab) in patients with non-small cell lung cancer (NSCLC) or melanoma. Language: English read more

Tags: of trial phase patients


Lumenis Announces UltraPulse with SCAAR FX Clinical Data to be Presented at the 16th European Burns Association Congress

2015-09-21 12:31:21| Industrial Newsroom - All News for Today

Lumenis Ltd. (NASDAQ: LMNS), the world's largest energy-based medical device company for aesthetic, surgical, and ophthalmic applications, announced today that two oral presentations showing the benefit of the UltraPulse in the treatment of patients with severe burn injuries will be presented at the 16th European...

Tags: data presented association european


PharmaCyte Biotech Discusses Major Milestones Ahead of Phase 2b Clinical Trial in Pancreatic Cancer

2015-09-15 15:58:58| Biotech - Topix.net

PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , discussed today some of the major "milestone" tasks that must be completed to begin its Phase 2b clinical trial in pancreatic cancer. The trial will test the effectiveness and safety of PharmaCyte Biotech's pancreatic cancer treatment.

Tags: major trial phase ahead


VA Spinal Cord Injury Center Demonstrates Clinical Improvement with the EarlySense Monitoring System

2015-09-14 12:31:15| Industrial Newsroom - All News for Today

Data presented at ASCIP Educational Conference WALTHAM, Massachusetts,  - A VA Spinal Cord Injury (SCI) Center has reported significant positive clinical results achieved with the EarlySense Monitoring System. The Scientific Poster was presented at the Academy of Spinal Cord Injury Professionals (ASCIP) 2015...

Tags: system center improvement monitoring


RedHill Biopharma - 9 Late Stage Clinical Assets, $150 Million Market Cap - Is It Undervalued?

2015-09-11 14:41:16| Biotech - Topix.net

Every market day, we select up to 20 of our authors' top long and short ideas, exclusively for PRO subscribers. RedHill focuses on late stage oral gastrointestinal drugs; the company has two potential blockbusters in Phase 3 studies, 9 active clinical programs in total.

Tags: is it market million


Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] next »